Literature DB >> 3480008

Dihydrofolate reductase-activity in brain tissue. Effect of X-irradiation.

R Ludwig1, E Frei, B Kimmig, W E Brandeis.   

Abstract

The mechanism responsible for the toxic late effects of cranial irradiation, followed by the administration of systemic methotrexate (MTX) on brain tissue, is still under discussion. We studied the influence of X-irradiation on dihydrofolate reductase (E.C. 1.5.1.3) activity (DHFR), the enzyme inhibited by MTX. New Zealand white rabbits, 6-9 weeks old, underwent 24 Gy fractionated or 20 Gy single-dose brain irradiation using a 60Co source. Before, immediately following, and 1, 2, 4, 12 weeks after irradiation, DHFR was measured in brain and liver tissue by a photometric assay. DHFR in brain tissue was 11.9 +/- 2.9 mU/g wet weight (ww) X h and in liver tissue 121.8 +/- 24.2 mU/g ww X h. Fractionated brain irradiation with 2 Gy per day produced no significant changes in brain DHFR. Single-dose cranial irradiation significantly decreased brain DFHR (7.3 +/- 0.6 mU/g ww X h). Suppression of the developmental increase of DHFR by X-irradiation in young rabbits could be excluded by determining the unchanged brain-to-liver ratios of DHFR in the animals with fractionated brain irradiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480008     DOI: 10.1007/BF00320216

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  The effect of x-irradiation on the metabolism of folic acid in rat organs.

Authors:  K GUGGENHEIM; S HALEVY; A HOCHMAN; M BEN-PORATH
Journal:  Radiat Res       Date:  1960-05       Impact factor: 2.841

2.  The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice.

Authors:  T W Griffin; J S Rasey; W A Bleyer
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

3.  Impaired development of rat liver enzyme activities at birth after irradiation in utero.

Authors:  C H Smith; M L Shore
Journal:  Radiat Res       Date:  1966-12       Impact factor: 2.841

Review 4.  The clinical pharmacology of methotrexate.

Authors:  J H Schornagel; J G McVie
Journal:  Cancer Treat Rev       Date:  1983-03       Impact factor: 12.111

5.  Efficacy and morbidity of central nervous system "prophylaxis" in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate.

Authors:  A Inati; S E Sallan; J R Cassady; S Hitchcock-Bryan; L A Clavell; J A Belli; N Sollee
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

6.  Effect of X-irradiation on the pharmacokinetics of methotrexate in rats: alteration of the blood-brain barrier.

Authors:  A J Storm; A J van der Kogel; K Nooter
Journal:  Eur J Cancer Clin Oncol       Date:  1985-06

7.  Abnormal computed tomography brain scans in children with acute lymphoblastic leukemia: serial long-term follow-up.

Authors:  R Riccardi; P Brouwers; G Di Chiro; D G Poplack
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

8.  In situ methotrexate polyglutamate formation in rat tissues.

Authors:  G R Krakower; B A Kamen
Journal:  J Pharmacol Exp Ther       Date:  1983-12       Impact factor: 4.030

9.  Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia.

Authors:  J H Rowland; O J Glidewell; R F Sibley; J C Holland; R Tull; A Berman; M L Brecher; M Harris; A S Glicksman; E Forman
Journal:  J Clin Oncol       Date:  1984-12       Impact factor: 44.544

10.  Neurologic sequelae of methotrexate and ionizing radiation: a new classification.

Authors:  W A Bleyer
Journal:  Cancer Treat Rep       Date:  1981
View more
  1 in total

1.  Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.

Authors:  L Bonafé; B Thöny; J M Penzien; B Czarnecki; N Blau
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.